Literature DB >> 27058636

Contrast-Enhanced Ultrasound (CEUS) of the Kidneys by Using the Bosniak Classification.

J Rübenthaler1, F Bogner1, M Reiser1, D A Clevert1.   

Abstract

Ultrasound is the most used interdisciplinary non-ionizing imaging technique in clinical routine. Therefore, ultrasound has a special value in the diagnosis and monitoring of cystic renal lesions, which can be classified as non-complicated or complicated and by means of occurrence as solitary or multifocal lesions. The Bosniak classification (I-IV) classifies renal cysts in 5 different categories with the help of ultrasound and computed tomography image criteria and is used for decisions of further clinical treatment. Additionally to normal native B-mode sonography, several new methods are in clinical use to improve diagnostic accuracy of unclear cases. Contrast enhanced ultrasound and MRI/CT are able to find and characterize difficult pathologies. This review explains the most important pathologies of cystic lesions of the kidney and stresses the different imaging methods of native B-mode sonography and the new techniques of contrast enhanced ultrasound. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27058636     DOI: 10.1055/s-0042-104646

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  9 in total

1.  Contrast-enhanced ultrasound of the kidney: a single-institution experience.

Authors:  Sheng F Oon; Robert W Foley; Deirdre Quinn; David M Quinlan; Robert G Gibney
Journal:  Ir J Med Sci       Date:  2017-12-07       Impact factor: 1.568

2.  Evaluation of renal lesions using contrast-enhanced ultrasound (CEUS); a 10-year retrospective European single-centre analysis.

Authors:  Johannes Rübenthaler; G Negrão de Figueiredo; K Mueller-Peltzer; D A Clevert
Journal:  Eur Radiol       Date:  2018-05-09       Impact factor: 5.315

Review 3.  [CEUS-diagnosis of benign liver lesions].

Authors:  K Müller-Peltzer; J Rübenthaler; G Negrao de Figueiredo; D A Clevert
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

Review 4.  [Reliable diagnosis of cystic renal lesions].

Authors:  K Müller-Peltzer; G Negrão de Figueiredo; V Schwarze; J Rübenthaler; D A Clevert
Journal:  Radiologe       Date:  2018-10       Impact factor: 0.635

5.  Clinical use of contrast-enhanced ultrasound beyond the liver: a focus on renal, splenic, and pancreatic applications.

Authors:  Giorgia Tedesco; Alessandro Sarno; Giulio Rizzo; Annamaria Grecchi; Ilaria Testa; Gabriele Giannotti; Mirko D'Onofrio
Journal:  Ultrasonography       Date:  2018-12-30

6.  Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Bosniak III Complex Renal Cystic Lesions-A 10-Year Specialized European Single-Center Experience with Histopathological Validation.

Authors:  Vincent Schwarze; Johannes Rübenthaler; Saša Čečatka; Constantin Marschner; Matthias Frank Froelich; Bastian Oliver Sabel; Michael Staehler; Thomas Knösel; Thomas Geyer; Dirk-André Clevert
Journal:  Medicina (Kaunas)       Date:  2020-12-12       Impact factor: 2.430

7.  Role of contrast-enhanced ultrasound in assessing indeterminate renal lesions and Bosniak ≥2F complex renal cysts found incidentally on CT or MRI.

Authors:  Giuseppe Como; Claudio Valotto; Francesco Tulipano Di Franco; Gianluca Giannarini; Lorenzo Cereser; Rossano Girometti; Chiara Zuiani
Journal:  Br J Radiol       Date:  2021-08-31       Impact factor: 3.039

8.  A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist's Perspective.

Authors:  Tomas Pitra; Kristyna Pivovarcikova; Reza Alaghehbandan; Adriena Bartos Vesela; Radek Tupy; Milan Hora; Ondrej Hes
Journal:  Cancers (Basel)       Date:  2022-02-06       Impact factor: 6.639

Review 9.  [CEUS-diagnostic workup of cystic renal lesions].

Authors:  J Rübenthaler; K Mueller-Peltzer; G Negrão de Figueiredo; E Gresser; D A Clevert
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.